Invention Grant
- Patent Title: Uracyl spirooxetane nucleoside phosphoramidates
- Patent Title (中): 尿嘧啶螺吡啶核苷氨基磷酸酯
-
Application No.: US13884852Application Date: 2011-11-10
-
Publication No.: US09012428B2Publication Date: 2015-04-21
- Inventor: Tim Hugo Maria Jonckers , Pierre Jean-Marie Bernard Raboisson , Koen Vandyck , Steven Maurice Paula Van Hoof , Lili Hu , Abdellah Tahri
- Applicant: Tim Hugo Maria Jonckers , Pierre Jean-Marie Bernard Raboisson , Koen Vandyck , Steven Maurice Paula Van Hoof , Lili Hu , Abdellah Tahri
- Applicant Address: US PA Horsham SE Huddinge
- Assignee: Janssen Products, LP,Medivir AB
- Current Assignee: Janssen Products, LP,Medivir AB
- Current Assignee Address: US PA Horsham SE Huddinge
- Priority: EP10190660 20101110
- International Application: PCT/EP2011/069865 WO 20111110
- International Announcement: WO2012/062870 WO 20120518
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K9/28 ; C07H19/06 ; C07H19/10 ; A61K9/20
Abstract:
This invention relates to a stereochemically pure uracyl spirooxetane nucleoside phosphoramidate useful in the treatment of patients infected with the hepatitis C virus (HCV).
Public/Granted literature
- US20130244968A1 Uracyl Spirooxetane Nucleoside Phosphoramidates Public/Granted day:2013-09-19
Information query
IPC分类:
